Ever Source Wealth Advisors, LLC Biocryst Pharmaceuticals Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 2,265 shares of BCRX stock, worth $15,696. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,265
Previous 1,070
111.68%
Holding current value
$15,696
Previous $8,000
150.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BCRX
# of Institutions
313Shares Held
201MCall Options Held
930KPut Options Held
553K-
Vanguard Group Inc Valley Forge, PA20.5MShares$142 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$138 Million0.0% of portfolio
-
State Street Corp Boston, MA8.51MShares$58.9 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.46MShares$58.7 Million9.06% of portfolio
-
Alkeon Capital Management LLC New York, NY5.71MShares$39.6 Million0.09% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.29B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...